Vectofusin-1 Improves Transduction of Primary Human Cells with Diverse Retroviral and Lentiviral Pseudotypes, Enabling Robust, Automated Closed-System Manufacturing
-
- Constanze Radek
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
-
- Ornellie Bernadin
- CIRI—International Center for Infectiology Research, Team EVIR, Université de Lyon, Lyon, France.
-
- Katharina Drechsel
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
-
- Nicole Cordes
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
-
- Rita Pfeifer
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
-
- Pia Sträßer
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
-
- Mirella Mormin
- Integrare Research Unit UMR_S951, Genethon, INSERM, University Evry, EPHE, Evry, France.
-
- Alejandra Gutierrez-Guerrero
- CIRI—International Center for Infectiology Research, Team EVIR, Université de Lyon, Lyon, France.
-
- François-loïc Cosset
- CIRI—International Center for Infectiology Research, Team EVIR, Université de Lyon, Lyon, France.
-
- Andrew D. Kaiser
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
-
- Thomas Schaser
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
-
- Anne Galy
- Integrare Research Unit UMR_S951, Genethon, INSERM, University Evry, EPHE, Evry, France.
-
- Els Verhoeyen
- CIRI—International Center for Infectiology Research, Team EVIR, Université de Lyon, Lyon, France.
-
- Ian C.D. Johnston
- Miltenyi Biotec B.V. & Co. KG, Bergisch Gladbach, Germany.
収録刊行物
-
- Human Gene Therapy
-
Human Gene Therapy 30 (12), 1477-1493, 2019-12-01
Mary Ann Liebert Inc